Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With AML and High-Risk MDS.

This study has been completed.

Study NCT00088218 Information provided by M.D. Anderson Cancer Center

First Received: July 22, 2004 Last Updated: August 31, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2008
Primary Completion Date:	February 2008 (Final data collection date for primary outcome measure)